A detailed history of Ally Bridge Group (Ny) LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 1,059,582 shares of PMN stock, worth $1.22 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
1,059,582
Previous 1,059,582 -0.0%
Holding current value
$1.22 Million
Previous $2.02 Million 21.45%
% of portfolio
1.49%
Previous 1.78%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.28 - $2.81 $9,077 - $19,928
-7,092 Reduced 0.66%
1,059,582 $2.02 Million
Q4 2023

Feb 14, 2024

BUY
$0.97 - $2.0 $518,716 - $1.07 Million
534,759 Added 100.53%
1,066,674 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$1.52 - $6.19 $808,510 - $3.29 Million
531,915 New
531,915 $1.05 Million

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.